E.U. Approves J&J Buyout Of Pfizer Unit
“The transaction proposes a major restructuring of the over-the-counter pharmaceutical and personal care product segment in Europe. The remedies offered by J&J fully address the concerns we had identified…I am thus confident that these markets will remain competitive,” said Competition Commissioner Neelie Kroes.
J&J first announced that it...
To view the full article, register now.